The Board of Directors of Indokem Limited, at its meeting held on Monday, May 4, 2026, approved the standalone and consolidated audited financial results for the quarter and year ended March 31, 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The statutory auditors, M/s. CNK & Associates LLP, Chartered Accountants, Mumbai, issued audit reports with an unmodified opinion on both sets of financial results. The board meeting commenced at 03:00 P.M. and concluded at 04:35 P.M.

Standalone Financial Performance

On a standalone basis, Indokem recorded a notable improvement in profitability for the year ended March 31, 2026. Net profit for FY26 stood at ₹213 lakhs, compared to ₹92 lakhs in FY25, reflecting a significant year-on-year improvement. Total income from operations, however, moderated to ₹15,128 lakhs from ₹15,430 lakhs in the prior year. The following table summarises the key standalone financial metrics:

On the cost side, total expenses for FY26 were ₹14,915 lakhs compared to ₹15,339 lakhs in FY25. Cost of materials consumed stood at ₹10,106 lakhs (FY25: ₹10,931 lakhs), while employee benefits expense increased to ₹1,782 lakhs from ₹1,602 lakhs. Finance costs rose to ₹337 lakhs from ₹272 lakhs. Paid-up equity share capital remained unchanged at ₹2,789 lakhs (face value of ₹10 each).

Standalone Balance Sheet Highlights

As at March 31, 2026, standalone total assets stood at ₹13,418 lakhs, compared to ₹13,021 lakhs as at March 31, 2025. Total equity increased to ₹5,531 lakhs from ₹5,318 lakhs. Key balance sheet items are presented below:

Cash and cash equivalents at the end of FY26 stood at ₹128 lakhs, up from ₹46 lakhs at the beginning of the year. Non-current borrowings increased to ₹2,472 lakhs from ₹1,192 lakhs, while current borrowings declined to ₹210 lakhs from ₹1,020 lakhs.

Consolidated Financial Performance

The consolidated results encompass Indokem's subsidiaries — Indokem Bangladesh (Pvt.) Limited, Refnol Overseas Limited, and step-down subsidiary Tex Care Middle East LLC. Consolidated total income from operations for FY26 was ₹17,245 lakhs, compared to ₹17,881 lakhs in FY25. Consolidated net profit for FY26 stood at ₹185 lakhs, against ₹314 lakhs in FY25. The following table presents the key consolidated financial metrics:

Consolidated total assets as at March 31, 2026 were ₹14,501 lakhs (March 31, 2025: ₹14,087 lakhs). Total consolidated equity stood at ₹6,451 lakhs, up from ₹6,184 lakhs in the prior year. Net profit attributable to owners of the company for FY26 was ₹187 lakhs, while the non-controlling interest recorded a loss of ₹2 lakhs.

Labour Code Impact and Segment Information

The Government of India notified the implementation of four new Labour Codes effective November 21, 2025, by consolidating and rationalising 29 existing labour laws. The company estimated the financial implications and took an additional charge of ₹90.39 lakhs in the financial results for the year ended March 31, 2026. The company and the group operate in two segments — textile dyes and chemicals, and electrical capacitors. Segment reporting for electrical capacitors is not disclosed separately, as it does not qualify for separate disclosure as per Ind-AS 108 on operating segments.

Key Board Decisions

In addition to approving the financial results, the Board took several significant governance decisions at the May 4, 2026 meeting:

• Reappointment of Mr. Arupkumar Basu (DIN: 00906760) as Managing Director for a term of three consecutive years from September 29, 2026 to September 28, 2029 (both days inclusive), subject to member approval at the forthcoming Annual General Meeting.
• Reappointment of Mr. Manish M. Khatau (DIN: 02952828) as Whole-time Director for a term of three consecutive years from March 1, 2027 to February 28, 2030 (both days inclusive), subject to member approval at the forthcoming Annual General Meeting.
• Reappointment of Mr. Mukund Nagpurkar as Internal Auditor for the financial year 2026-27.
• Noting of the Annual Secretarial Compliance Report and Secretarial Audit Report for the financial year 2026-27, received from M/s. Mayur More & Associates, Company Secretaries.
• Adoption of a revised Nomination and Remuneration Policy to align with updated regulatory requirements.

The declaration of unmodified opinion was confirmed by Mahendra K. Khatau, Chairman and Managing Director, and Sivarama Gunturi, Chief Financial Officer, in compliance with Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Indokem Limited has announced that its Board of Directors will meet on Monday, 04 May 2026 at 3:00 p.m. to consider the audited standalone and consolidated financial results for the quarter and year ended 31 March 2026. The intimation was sent to BSE Limited on 27 April 2026, pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Trading Window Closure

In accordance with the Company's Code of Conduct to regulate, monitor, and report trading by insiders, adopted pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window has been closed since 01 April 2026. The window will reopen 48 hours after the declaration of the financial results.

Meeting Details

The communication was signed by Rajesh D. Pisal, Company Secretary and Compliance Officer of Indokem Limited. The company's registered office is located at Khatau House, Ground Floor, Mogul Lane, Mahim (West), Mumbai - 400 016.